$272 Million is the total value of HARVEY CAPITAL MANAGEMENT INC's 82 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 76.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TTPH | Buy | TETRAPHASE PHARMACEUTICALS I | $11,647,000 | -4.1% | 317,900 | +4.0% | 4.28% | -8.0% |
EMC | Buy | EMC CORPORATION | $9,404,000 | +5.1% | 367,950 | +22.3% | 3.46% | +0.8% |
FEYE | Buy | FIREEYE INC | $8,328,000 | +153.4% | 212,200 | +103.8% | 3.06% | +142.9% |
CEMP | New | CEMPRA INC | $7,381,000 | – | 215,150 | +100.0% | 2.71% | – |
GOOG | Buy | GOOGLE INCcl c | $7,261,000 | +5.1% | 13,250 | +1.0% | 2.67% | +0.8% |
OUT | Buy | OUTFRONT MEDIA INC COM ISIN #U | $5,711,000 | +11.7% | 190,894 | +0.2% | 2.10% | +7.1% |
PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $5,681,000 | +46.8% | 149,680 | +9.6% | 2.09% | +40.8% |
NVAX | Buy | NOVAVAX INC | $5,102,000 | +44.7% | 616,950 | +3.8% | 1.88% | +38.7% |
BABA | New | ALIBABA GROUP HOLDING-SPspon adr | $4,638,000 | – | 55,725 | +100.0% | 1.70% | – |
AERI | Buy | AERIE PHARMACEUTICALS INC | $4,619,000 | +16.9% | 147,400 | +8.9% | 1.70% | +12.1% |
PRU | New | PRUDENTIAL FINANCIAL INC | $3,709,000 | – | 46,187 | +100.0% | 1.36% | – |
PFPT | New | PROOFPOINT INC | $3,620,000 | – | 61,135 | +100.0% | 1.33% | – |
HXL | Buy | HEXCEL | $3,465,000 | +25.4% | 67,400 | +1.2% | 1.27% | +20.3% |
NKTR | Buy | NEKTAR THERAPEUTICS | $3,451,000 | +1.1% | 313,800 | +42.4% | 1.27% | -3.1% |
MUI | Buy | BLACKROCK MUNI INTER DURATION | $2,739,000 | +3.4% | 186,500 | +1.4% | 1.01% | -0.8% |
EOG | Buy | EOG RESOURCES INC | $2,184,000 | +1.1% | 23,830 | +1.5% | 0.80% | -3.0% |
DIS | Buy | THE WALT DISNEY CO | $2,162,000 | +12.0% | 20,620 | +0.6% | 0.80% | +7.4% |
DISCA | New | DISCOVERY COMMUNICATIONS INC N | $1,894,000 | – | 61,600 | +100.0% | 0.70% | – |
PVAHQ | Buy | PENN VIRGINIA CORP | $1,101,000 | -0.5% | 170,000 | +2.7% | 0.40% | -4.5% |
HYG | Buy | ISHARES TR IBOXX $ HIGH YIELDiboxx hi yd et | $1,078,000 | +2.9% | 11,900 | +1.7% | 0.40% | -1.5% |
ASPX | Buy | AUSPEX PHARMACEUTICALS INC | $977,000 | +193.4% | 9,750 | +53.5% | 0.36% | +180.5% |
RAD | New | RITE AID CORPORATION | $955,000 | – | 110,000 | +100.0% | 0.35% | – |
QURE | New | UNIQURE N.V. COM EUR0.05 | $537,000 | – | 22,100 | +100.0% | 0.20% | – |
JNJ | Buy | JOHNSON JOHNSON | $523,000 | +0.2% | 5,200 | +4.0% | 0.19% | -4.0% |
PFE | New | PFIZER INC | $347,000 | – | 10,000 | +100.0% | 0.13% | – |
SLB | New | SCHLUMBERGER LTD | $333,000 | – | 4,000 | +100.0% | 0.12% | – |
JPM | New | JP MORGAN CHASE | $302,000 | – | 5,000 | +100.0% | 0.11% | – |
OKE | New | ONEOK INC | $241,000 | – | 5,000 | +100.0% | 0.09% | – |
IR | New | INGERSOLL-RAND PLC SHS USD1 | $204,000 | – | 3,000 | +100.0% | 0.08% | – |
MRNS | New | MARINUS PHARMACEUTICALS INC CO | $134,000 | – | 15,000 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-05
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
APPLE COMPUTER INC | 45 | Q2 2024 | 9.0% |
MICROSOFT CORP | 45 | Q2 2024 | 7.8% |
COMCAST CL A VTG | 45 | Q2 2024 | 1.7% |
ISHARES SP 500 INDEX FUND | 45 | Q2 2024 | 1.8% |
SOCIEDAD QUIMICA MINERA DE CHI | 45 | Q2 2024 | 1.0% |
BERKSHIRE HATHAWAY INC. CL-A | 45 | Q2 2024 | 0.4% |
ISHARES SP500/BARRA GROWTH IN | 45 | Q2 2024 | 0.2% |
BERKSHIRE HATHAWAY INC DEL | 43 | Q2 2024 | 2.8% |
HONEYWELL INTL INC | 43 | Q2 2024 | 3.2% |
JOHNSON JOHNSON | 43 | Q2 2024 | 0.5% |
View HARVEY CAPITAL MANAGEMENT INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-27 |
13F-HR | 2024-07-22 |
13F-HR | 2024-05-10 |
13F-HR | 2024-01-29 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-04 |
13F-HR/A | 2023-05-17 |
13F-HR | 2023-05-16 |
13F-HR | 2023-02-27 |
13F-HR | 2022-11-14 |
View HARVEY CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.